From a small team of researchers and skipped salaries, CEO Michelle Xia has steered Akeso to become one of the most exciting companies in the industry today.
Choosing China: Akeso’s $3M Beginnings and the Rise of China’s Biotech Sector Read More »
While the FDA is trumpeting this new initiative as “sweeping reforms” to the way drug companies can advertise, experts say the regulator is going after a problem that doesn’t exist.
In New DTC Ad Crackdown, FDA Trying to Close a Loophole That Isn’t Read More »
The FDA has vowed to fix a pharma ad loophole—but they’re targeting the wrong one.
Serena Williams Hawks GLP-1s For Ro Even as Pharmas Face Tightening Oversight Read More »
La transición energética no solo responde a una necesidad ambiental, también representa una oportunidad económica para México. La innovación tecnológica está transformando cómo empresas, hogares y gobiernos gestionan la energ&i …
Tecnologías verdes: el rol de la innovación en la transición energética Read More »
Flavia Pease will take over as Insulet’s CFO on Sept. 30. Elsewhere, outgoing Dexcom CEO Kevin Sayer is taking a medical leave of absence.
Eighteen blue state governors are warning of a looming affordability cliff for millions of Americans if lawmakers allow generous financial assistance to lapse at the end of this year.
Democrat governors urge Congress to extend ACA subsidies Read More »
A decade-long journey is coming to an end for Stealth BioTherapeutics and the Barth syndrome community. Will it result in the first-ever treatment for this ultra-rare mitochondrial disease, or possibly the end of the road for the Massachusetts-based biotech?
Stealth, Barth Community Await FDA Verdict With ‘Everything at Stake’ Read More »
The sub-analysis, presented at the European Association for the Study of Diabetes congress, showed improved safety data to counteract past tolerability issues.
Novo’s Amylin Injectable Cagrilintide Hits 11.8% Weight Reduction in Phase III Trial Read More »
A new analyst survey suggests that doctors are still prescribing Sarepta’s Elevidys, even after a series of deaths in certain populations marred the gene therapy’s record.
Doctors Still Prescribing Sarepta’s DMD Gene Therapy After Safety Concerns Read More »
States have been anticipating more details about the Rural Health Transformation Fund since July. Now, they will have until Nov. 5 to submit applications for a piece of the $50 billion dollar pie.
CMS opens applications for Rural Health Transformation Fund Read More »
